成纤维细胞激活蛋白靶向PET/CT在多种非缺血性心肌病中的应用
纳入50例不同亚型非缺血性心肌病患者行[68Ga]Ga-FAPI-04 PET/CT,64%(32/50)为阳性,其中16例呈斑片状摄取、16例呈弥漫性摄取。弥漫性摄取组的左心室分子体积、SUVr和SUVmean均显著高于斑片状摄取组,且FAPI摄取与NT-proBNP升高及左心室收缩功能异常相关。
要点
- 50例非缺血性心肌病患者中64%(32/50)[68Ga]Ga-FAPI PET/CT阳性,斑片状与弥漫性摄取各16例。
- 弥漫性摄取组LVMV、SUVr、SUVmean均显著高于斑片状摄取组。
- FAPI摄取与NT-proBNP及超声左心室收缩功能指标显著相关。
核心结论
- [68Ga]Ga-FAPI PET/CT在非缺血性心肌病中显示多样心肌成纤维细胞激活,与心室收缩功能受损及NT-proBNP升高相关,作者认为其有潜力作为早期疾病检测和风险分层的影像工具。
研究设计与样本
- 纳入50例不同亚型非缺血性心肌病患者,均行[68Ga]Ga-FAPI-04 PET/CT,阳性定义为左心室FAPI活性高于血池。
- 采用半自动定量方法计算左心室分子体积(LVMV)、SUVr和SUVmean,分析FAPI摄取值与心室功能的相关性。
主要发现
- 64%(32/50)患者PET阳性,其中16例呈斑片状摄取、16例呈弥漫性摄取。
- 弥漫性摄取组LVMV为254.5(107.7–404.0),斑片状摄取组为20.9(4.5–31.3),p < 0.0001。
- 弥漫性摄取组SUVr为4.7(3.2–6.7),斑片状摄取组为2.3(2.0–3.0),p = 0.0003。
- 弥漫性摄取组SUVmean为2.8(2.2–3.5),斑片状摄取组为2.1(1.6–2.4),p = 0.0147。
- [68Ga]Ga-FAPI摄取值与NT-proBNP及超声评估的左心室收缩功能指标(左心室射血分数、左心室舒张末期内径、左心室舒张末期内径)显著相关(p < 0.05);扩张型心肌病亚组(n = 13)中FAPI摄取与超声参数的相关性亦被观察到(p < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Fibroblast activation protein (FAP)-targeted PET/CT can visualize activated fibroblasts, offering us the opportunity to identify myocardial fibrosis at an early stage. We aimed to establish a preliminary mapping of [68Ga]Ga-FAPI PET/CT in patients with non-ischemic cardiomyopathy (NICM), and to explore the correlation between myocardial FAPI uptake and cardiac function. METHODS: Fifty patients with different subtypes of NICM were enrolled. All patients underwent [68Ga]Ga-FAPI-04 PET/CT. A positive PET scan was defined as increased left ventricular (LV) FAPI activity than blood pool. LV molecular volume (LVMV), SUVr and SUVmean were calculated using a semi-automatic quantification method. The correlations between FAPI-uptake values and ventricular function were analyzed. RESULTS: Among all patients, 64% (32/50) exhibited a positive PET scan, with 16 patients demonstrating with patchy uptake and another 16 patients displaying with extensive uptake. LVMV, SUVr, and SUVmean were significantly higher in patients with extensive uptake than those with patchy uptake [LVMV, 254.5 (107.7–404.0) vs. 20.9 (4.5–31.3), p < 0.0001; SUVr, 4.7 (3.2–6.7) vs. 2.3 (2.0–3.0), p = 0.0003; SUVmean, 2.8 (2.2–3.5) vs. 2.1 (1.6–2.4), p = 0.0147]. Notably, [68Ga]Ga-FAPI uptake values significantly correlated with N-terminal pro–brain natriuretic peptide (NT-proBNP), and abnormal LV contractile function assessed by echocardiography, including LV ejection fraction, LV end-diastolic dimension, and LV end-diastolic dimension (p < 0.05). In subgroup analysis focusing on patients with dilated cardiomyopathy (n = 13), the correlation between [68Ga]Ga-FAPI uptake and echocardiographic parameters was also observed (p < 0.05). CONCLUSIONS: [68Ga]Ga-FAPI PET/CT demonstrated diverse myocardial fibroblast activation in NICM, which correlated with impaired ventricular contractile function and elevated NT-proBNP levels. These findings highlight its potential as a valuable imaging tool for early disease detection and risk stratification in NICM.
引用
- Yang Q, Xue S, Ren C, et al. Fibroblast activation protein-targeted PET/CT in multiple non-ischemic cardiomyopathies. Eur J Nucl Med Mol Imaging. 2025. PMID: 40504387. doi:10.1007/s00259-025-07385-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。